Publication | Closed Access

Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice

InflammationAllergyInflammatory Lung DiseaseLung InflammationMedicineRespiratory ToxicologyPulmonary PharmacologyPharmacologyLipopolysaccharide-induced Airway InflammationHydrogen SulfideIntranasal TreatmentOxidative StressInhalation Toxicology